Article | March 12, 2020

Changes To Research Made In Response To COVID-19

Source: WCG

WIRB-Copernicus IRB has received questions from several research sponsors about the appropriate process for making changes to clinical studies in response to the current COVID-19 epidemic. These changes may include things like:

  • Decreasing the number of protocol-mandated in-person study visits to healthcare facilities
  • Replacing protocol-mandated visits to healthcare facilities with home visits or telemedicine,
    allowing blood draws at remote or commercial laboratories
  • Shipping investigational products directly to research participants

access the Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

WCG